If you have been reading about elevated plus maze and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
== External links == Media related to Copper(II) sulfate at Wikimedia Commons International Chemical Safety Card 0751 International Chemical Safety Card 1416 National Pollutant Inventory – Copper and compounds fact sheet
== History == The existence of tRNA was first hypothesized by Francis Crick as the "adaptor hypothesis" based on the assumption that there must exist an adapter molecule capable of mediating the translation of the RNA alphabet into the protein alphabet. Paul C Zamecnik, Mahlon Hoagland, and Mary Louise Stephenson discovered tRNA in 1958. Significant research on structure was conducted in the early 1960s by Alex Rich and Donald Caspar, two researchers in Boston, the Jacques Fresco group in Princeton University and a United Kingdom group at King's College London. In 1965, Robert W. Holley of Cornell University reported the primary structure and suggested three secondary structures. tRNA was first crystallized in Madison, Wisconsin, by Robert M. Bock. The cloverleaf structure was ascertained by several other studies in the following years and was finally confirmed using X-ray crystallography studies in 1974. Two independent groups, Kim Sung-Hou working under Alexander Rich and a British group headed by Aaron Klug, published the same crystallography findings within a year.
That's exactly what I didn't want to happen." One of Staley's last shows with Alice in Chains was the MTV Unplugged performance in New York on April 10, 1996. The recording of Unplugged came after a long period of inactivity for the band; it was their first concert in two-and-a-half years. Staley made his last performance on July 3, 1996, in Kansas City, Missouri, while Alice in Chains was touring with Kiss.
So much so that it was considered an aphrodisiac and given to the Inca soldiers during campaigns to make them forget about their spouses. Other roots that could be found in the Inca cuisine were the maka (Lepidium meyenii) and the yacón (Polymnia sonchifolia). Maka was capable of surviving in the coldest and highest areas of the Andes, thus giving it high value. Yacón was documented to be similar to a turnip in texture but was very sweet and kept well, making them popular on sea voyages. The insipid, starchy root ullucu, and arracacha, something like a cross between carrot and celery, were, like potatoes, used in stews and soup. Achira, a species of Canna, was a sweet, starchy root that was baked in earth ovens. Since it had to be transported up to the power center of Cuzco, it is considered to have been food eaten as part of a tradition. Although the roots and tubers provided the staples of the Inca, they were still considered lower in rank than maize (Zea mays). It has been found that the Inca-conquered lands were often transitioned from potato fields to maize fields, more than likely due to maize being the main ingredient of chicha. Several species of seaweed, such as Porphyra, Durvillaea antarctica, and Ulva lactuca were part of the Inca diet and could be eaten fresh or dried. Some freshwater algae and blue algae of the genus Nostoc were eaten raw or processed for storage. In post-colonial times it has been used to make a dessert by boiling it in sugar.
== External links == Media related to Protons at Wikimedia Commons Particle Data Group at LBL Large Hadron Collider Eaves, Laurence; Copeland, Ed; Padilla, Antonio (Tony) (2010). "The shrinking proton". Sixty Symbols. Brady Haran for the University of Nottingham. MIT proton visualization project: Inside the Proton, the 'Most Complicated Thing You Could Possibly Imagine', Quanta Magazine, Oct 19 2022 Visualizing the Proton, Arts at MIT, 2022
Sources: en.wikipedia.org
== Nanocellulose based water purification system == Nanocellulose based renewable material has a combination of high surface area with high material strength. It is chemically inert and possesses versatile hydrophilic surface chemistry. These properties make them a most promising nanomaterial for usage as a membrane and filter in water purification systems to remove bacterial and chemical contaminants from polluted water. It is noted that nanocellulose material has high potential in water purification technology. Different types of nanocellulose materials available for water purification system includes Cellulose nanocrystals (CNC) and Cellulose nanofibrils (CNF). These are the rod-like nanomaterials whose size ranges from 100 to 2000 nm with the diameter of 2 to 20 nm. Those length and diameter are mostly based on origin and preparation route for the synthesis of nanocellulose. Those nanocellulose materials are used to remove organic pollutants in water such as dyes, oils and pesticides traces present in water. Currently, fully biobased membrane using nanocellulose are fabricated which is used to remove metal ions such as Cu2+, Fe2+ etc, sulfates, fluorides and other organic compounds. This bio-based nanocellulose filter has more advantage to conventional filters. Nanocellulose is prepared by various methods such as sulphuric acid hydrolysis and mechanical grinding method. Water purification system is mainly based on the principle of absorption.
=== Menopause === During menopause, hormone levels decrease, which causes changes in the vulva known as vulvovaginal atrophy. The decreased estrogen affects the mons, the labia, and the vaginal opening and can cause pale, itchy, and sore skin. Other visible changes are a thinning of the pubic hair, a loss of fat from the labia majora, a thinning of the labia minora, and a narrowing of the vaginal opening. This condition has been renamed by some bodies as the genitourinary syndrome of menopause as a more comprehensive term.
The first elections took place in January 1889 and the county council formally came into being on 1 April 1889. On that day its first official meeting was held at the old Shire Hall on Old Elvet in Durham, the courthouse (built 1811) which had served as the meeting place of the quarter sessions which preceded the county council. The first chairman of the council was John Lloyd Wharton, who was the Conservative Member of Parliament for Ripon (in Yorkshire); he had also been chairman of the Durham Quarter Sessions since 1871. Durham was the first county council to be controlled by the Labour Party, which won the most seats in 1919. In 1974, the county was redesignated as a non-metropolitan county under the Local Government Act 1972. As part of those reforms the county ceded territory in the north-east to the new county of Tyne and Wear and in the south-east to the new county of Cleveland, but gained the former Startforth Rural District covering the part of Teesdale south of the River Tees from the North Riding of Yorkshire, and Darlington was brought back under the county council's control. Until 1974, the lower tier of local government comprised numerous boroughs, urban districts and rural districts. The districts were also reorganised in 1974 into eight non-metropolitan districts: Chester-le-Street, Darlington, Derwentside, Durham, Easington, Sedgefield, Teesdale, and Wear Valley. In 1997, Darlington became a unitary authority, removing it from county council control.
== Career == Merker graduated as a physician at the Free University of Berlin in 1956. In 1957, he was employed at the Research Department of Electron Microscopy, which was headed by Willy Schwarz, at the Institute of Anatomy at the Free University of Berlin. He obtained his doctorate (Dr.med.) in 1958 and his Habilitation in 1964, and was appointed as Adjunct Professor (außerplanmäßiger Professor) at the Free University of Berlin in 1968. In 1969, he became director of the Research Department of Electron Microscopy. He held the first chair in anatomy from 1972 to 1998, in succession to Ernst von Herrath. He also served as Dean of the Faculty of Medicine from 1980 to 1981, and was director of the Institute of Anatomy until 1998. He was a visiting scholar for one year at the Weizmann Institute of Science in Israel in 1965, and was subsequently a visiting scholar at universities in England and Sweden. He wrote more than 250 scientific papers. He became Professor Emeritus in 1998, and died in Berlin in 2014.
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Reverse-phase HPLC is the usual method and gives a percentage purity value. Mass spectrometry then confirms the molecular mass. Together they provide a basic identity and purity profile for a lot.